Overview Financials News + Filings Key Docs Charts Ownership Insiders |
CODEXIS, INC. (CDXS)
|
Add to portfolio |
|
|
Price: |
$24.20
| | Metrics |
OS: |
69.8
|
M
| |
|
|
Market cap: |
$1.69
|
B
| |
|
|
Net cash:
|
$92.1
|
M
| |
$1.32
|
per share
|
EV:
|
$1.6
|
B
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 |
Revenues | 138.6 | 104.8 | 69.1 | 68.5 | 60.6 | 60.6 | 50.0 | 48.8 |
Revenue growth | 32.3% | 51.7% | 0.9% | 13.0% | 21.1% | | 2.4% | 16.8% |
Cost of goods sold | 38.0 | 22.2 | 13.7 | 15.6 | 12.6 | 12.6 | 14.3 | 9.8 |
Gross profit | 100.6 | 82.5 | 55.3 | 52.8 | 48.0 | 48.0 | 35.7 | 39.1 |
Gross margin | 72.6% | 78.8% | 80.1% | 77.2% | 79.2% | 79.2% | 71.4% | 80.0% |
Selling, general and administrative | 52.2 | 49.3 | 35.0 | 31.5 | 29.3 | 59.3 | 29.0 | 25.4 |
Research and development | 80.1 | 55.9 | 44.2 | 33.9 | 30.0 | | 29.7 | 22.2 |
EBITA | -31.7 | -22.7 | -23.9 | -12.5 | -11.3 | -11.3 | -23.0 | -5.8 |
EBITA margin | -22.9% | -21.7% | -34.6% | -18.3% | -18.6% | -18.6% | -45.9% | -11.8% |
Amortization of intangibles | | | | | | | | 2.8 |
EBIT | -31.7 | -22.7 | -23.9 | -12.5 | -11.3 | -11.3 | -23.0 | -8.6 |
EBIT margin | -22.9% | -21.7% | -34.6% | -18.3% | -18.6% | -18.6% | -45.9% | -17.5% |
Pre-tax income | -33.3 | -21.1 | -23.7 | -11.9 | -10.9 | -10.9 | -22.9 | -8.6 |
Income taxes | 0.3 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
Tax rate | | | | | 0.3% | 0.3% | | 0.5% |
Net income | -33.6 | -21.3 | -24.0 | -11.9 | -10.9 | -10.9 | -23.0 | -8.6 |
Net margin | -24.2% | -20.3% | -34.8% | -17.4% | -18.0% | -18.0% | -46.0% | -17.5% |
|
Diluted EPS | ($0.51) | ($0.33) | ($0.40) | ($0.21) | ($0.21) | ($0.21) | ($0.50) | ($0.21) |
Shares outstanding (diluted) | 65.3 | 64.6 | 59.4 | 56.5 | 52.2 | 52.2 | 46.2 | 40.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|